GPR120 agonists (Dompe farmaceutici)

N/A

Report date: 2025/03/20 15:28:27
NME

Base Information

Drug NameGPR120 agonists (Dompe farmaceutici)
Drug Alias NameGPR120 agonists (Dompe US)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 4 agonists
TargetsFree fatty acid receptor 4
Therapy Area/IndicationsDiabetes MellitusInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDompé Pharmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesDompé U.S. Inc
Inactive CompaniesDompé Pharmaceutici Spa
Active IndicationsDiabetes MellitusInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A